Bioelectronics is a branch of science dealing with the
role of electron transfer in biological processes. It works with electronic
control of physiological functions that is applied in medicine to restore the
lost functions of the nervous system.
Dust-sized Electroceuticals
UC
Berkeley (University of California, Berkeley) engineers have built dust-sized battery-less,
wireless sensors to monitor and stimulate muscles, organs, and nerves. These
implantable sensors or so-called neural dust could improve brain control of
prosthetics.
View summary of this report, Click Here
Currently,
implantable electrodes degrade within a year or two. They are also connected
with wires that pass through holes in the skull. These wireless sensors could
be sealed in, preventing infection and movement of the electrodes. Moreover, it
could prevent the use of wires running through the skull.
This
technology could open the doors for “electroceuticals” in treating of disorders
like epilepsy and stimulate immune system and reduce inflammation. When tested
on rats, the dust was implanted in the muscles and peripheral nerves. The
ultrasound is used to power and read out the data and measurements.
This
sensor is as large as a grain of sand, contains a piezoelectric crystal that
converts the external ultrasound vibrations into electricity to fuel a minute
on-board transistor, which is connected to the muscle fiber or nerve. A voltage
spike in the fiber could alter the circuit and vibrate the crystals changing
the echo detected by the receiver. Backscatter or slight changes allows the
researchers to alter the voltage. In the experiment, the passive sensors were
powered every 100 microseconds with six 540-nanosecond ultrasound pulses. This
gave the researchers a real-time readout. The researchers believe that these
sensors could perform well in the brain and central nervous system to control
prosthetics.
Market Insight
According
to a new report by Grand View Research, Inc., the global electroceuticals/bioelectric
medicine market is expected to reach USD 35.5 billion by 2025. Growing
geriatric population prone to ailments and diseases namely Alzheimer’s disease,
cardiac arrhythmias, depression, epilepsy, and Parkinson’s disease is
anticipated to drive the market over the coming years. Additionally, prevalence
of chronic disorders will also contribute to the market growth.
Competitive Insight
LivaNova
PLC; Medtronic; Nevro Corp.; and SECOND SIGHT are some of the major competitors
of the electroceuticals/bioelectric medicine market. Players get involved in collaborations,
mergers & acquisitions, product development, and regional expansions to
improve their position in the market.
Click Here For Access Full Report : https://goo.gl/1uqDWD
ConversionConversion EmoticonEmoticon